LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the chairman and CEO of Biohaven (BHVN). Published first ...

Trump’s latest trade war measures included a 26 per cent tariff on Indian exports, but the pharmaceutical sector escaped unscathed. With India being a key supplier of generic medicines to the US, the ...

The President has indicated in the past that tariffs on pharmaceuticals, semiconductors, and other industries would be revealed at a later date, although he did already apply a 25% tariff on ...

Indian pharma stocks were in focus on Thursday (April 3, 2025) early trading hours after the generic drugmakers got an exemption from U.S. tariff levy. Also read: Front-end manufacturing in U.S ...

Indian pharmaceutical stocks faced sharp losses following concerns over potential future tariffs, reversing the previous day's gains and adding uncertainty to the sector's outlook. CHENNAI ...

SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global ...

US Tariffs on Pharma: Jefferies believes that if the US applies reciprocal tariffs, it will at best be 10% on imported Indian medicines to the US.(Photo: Bloomberg) The US President Donald Trump's ...

It demands significant resources that are often expensive and inaccessible to biotechnology and pharmaceutical companies of all sizes. Federal regulations like the Current Good Manufacturing ...

In the latest in a growing trend of pharma reshuffling moves in Asia, Marubeni Corporation is absorbing Sumitomo Pharma’s operations in Asia to create a new company with a share purchase ...

Pharma stocks crashed 6 per cent before closing 4 per cent lower on Friday after US President Donald Trump reportedly threatened tariffs on pharma products at “levels never seen before.” ...

FIRST IN RxP: EYEING DTC AD TAX — New research suggests that limiting the pharmaceutical industry’s direct-to-consumer advertising — or eliminating one of its tax benefits — could save ...